Key result
Transdermal estradiol and progesterone emerge as preferred hormone therapy regimens for menopausal women.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Scarabin et al. (2020) studied this question. Transdermal estradiol and progesterone are promoted as preferred hormone therapy regimens for menopausal women.
Synapse has enriched 10 related papers. Consider them for comparative context: